At Zenopa we are very successful at securing Dental Sales roles for both clinical professionals looking to enter the commercial space, and experienced Sales talent looking for a sideways step into a ...

Bayer has embarked on a significant move to expand its pharmaceutical influence by applying for approval from the European Medicines Agency (EMA) for its new menopause drug, elinzanetant. Targeted at ...

Abbott is making significant strides in the diabetes technology sector, with CEO Robert Ford highlighting the potential of continuous glucose monitors (CGMs) to reach a wider market. This growth is ...

Alleo Labs, based in San Francisco, has partnered with Dundee’s Ubiquigent Limited to modernise drug discovery processes focusing on deubiquitinases (DUBs). This strategic alliance uses Alleo’s AI ...

BioAffinity Technologies’ (Nasdaq: BIAF) Vice President of Diagnostics, Jennifer Rebeles, Ph.D., was part of a panel of worldwide experts that published the peer-reviewed paper, “Implementation of ...

Refeyn, the company behind pioneering mass photometry technologies, has taken another step to assure mass photometry is a simpler, more efficient bioanalytics tool with the release of a powerful ...

Danish pharmaceutical company Lundbeck is making waves in the biopharma industry with its $2.6 billion acquisition of the biotechnology firm Longboard Pharmaceuticals. This strategic move targets the ...

APHA has introduced a new licence aimed at aiding cattle farmers affected by TB restrictions. This licence, known as TB24c, provides greater flexibility for TB-restricted herds by facilitating cattle ...

Are you a Dental professional with specialized skills in areas like Digital Design, Dental Technology, or Lab Work? We can help you find your next career opportunity. The Dental Technical industry ...

Roche’s Genentech has secured FDA approval for Itovebi, a treatment for HR-positive, HER2-negative breast cancer with PIK3CA mutations resistant to adjuvant endocrine therapy. This approval positions ...

A recent report highlights a significant inclination among NHS dental patients to consider private care, with six out of ten indicating openness to the switch. This shift is attributed to increasing ...

Today’s statistics reaffirm the need for reform and investment to get the NHS back on its feet. The waiting list for routine treatment grew slightly in August to 7.64 million cases. While very long ...